{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:50:11Z","timestamp":1793346611699,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kao Family Foundation"},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A growing number of centers offer hepatic artery infusion pump (HAIP) chemotherapy for advanced liver malignancies. While small series have demonstrated feasibility of robotic HAIP placement, comparison of outcomes with open placement is lacking. We compared outcomes after robotic versus open HAIP placement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively reviewed HAIP placement without concurrent hepatectomy at Memorial Sloan Kettering Cancer Center from 1 January 2011 to 15 September 2022, and Duke Health from 1 November 2018 to 18 May 2023. Patients with prior liver surgery or who required catheterization of a non-standard vessel were excluded. Propensity score matching weights (PSMW) were calculated using age, sex, race, body mass index, American Society of Anesthesiologists class, neoadjuvant chemotherapy, colorectal procedure, and institution. Survey-weighted generalized linear models assessed the relationship between approach and outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 2002 consecutive HAIP placements, 819 (645 open\/174 robotic) met the inclusion criteria. A higher proportion of open procedures involved combined colorectal procedures; other patient characteristics were similar. Overall, 15% of patients experienced an HAIP-specific complication and 12% required re-intervention; 2.7% had HAIP failure \u2264 90 days. After PSMW, the robotic approach had a longer operative time (<jats:italic>\u03b2<\/jats:italic>\u00a0=\u00a068\u00a0min, 95% confidence interval [CI] 55\u201381, <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001) but shorter length of stay (<jats:italic>\u03b2<\/jats:italic>\u00a0=\u00a0\u2212\u20091.8 days, 95% CI \u2212\u20092.3 to 1.3, <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001). The robotic approach was associated with increased HAIP-specific complications (odds ratio [OR] 1.72, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.025) and re-intervention (OR 2.33, <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001), with no difference in time to initiation of HAIP chemotherapy or HAIP failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Robotic HAIP placement was associated with increased postoperative complications and significantly shorter length of stay, with similar time to initiation of HAIP therapy. There was no difference in the rate of early HAIP failure versus the open approach. These results suggest robotic HAIP placement is feasible and effective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-16915-8","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T19:15:55Z","timestamp":1738091755000},"page":"3488-3498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Robotic Versus Open Placement of Hepatic Artery Infusion Pumps"],"prefix":"10.1245","volume":"32","author":[{"given":"Lauren E.","family":"Schleimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Kalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Bashir","family":"Barekzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur P.","family":"Choubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubiya","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Geevarghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Drebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Zani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Lidsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0406-017X","authenticated-orcid":false,"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"1","key":"16915_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12885-019-5515-6","volume":"19","author":"FE Buisman","year":"2019","unstructured":"Buisman FE, Homs MYV, Gr\u00fcnhagen DJ, et al. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases\u2014the multicenter randomized controlled PUMP trial. BMC Cancer. 2019;19(1):327.","journal-title":"BMC Cancer."},{"issue":"1","key":"16915_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","volume":"6","author":"A Cercek","year":"2020","unstructured":"Cercek A, Boerner T, Tan BR, et al. Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6(1):60\u20137.","journal-title":"JAMA Oncol."},{"issue":"2","key":"16915_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","volume":"261","author":"MI D\u2019Angelica","year":"2015","unstructured":"D\u2019Angelica MI, Correa-Gallego C, Paty PB, et al. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Ann Surg. 2015;261(2):353\u201360.","journal-title":"Ann Surg."},{"issue":"3 Suppl","key":"16915_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2024.42.3_suppl.433","volume":"42","author":"S Franssen","year":"2024","unstructured":"Franssen S, Rousian M, Nooijen LE, et al. Hepatic arterial infusion pump chemotherapy in patients with advanced intrahepatic cholangiocarcinoma confined to the liver: a multicenter phase II trial. J Clin Oncol. 2024;42(3 Suppl):433.","journal-title":"J Clin Oncol."},{"issue":"9","key":"16915_CR5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","volume":"20","author":"WR Jarnagin","year":"2009","unstructured":"Jarnagin WR, Schwartz LH, Gultekin DH, et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol. 2009;20(9):1589\u201395.","journal-title":"Ann Oncol."},{"issue":"9","key":"16915_CR6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","volume":"24","author":"NE Kemeny","year":"2006","unstructured":"Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24(9):1395\u2013403.","journal-title":"J Clin Oncol."},{"issue":"3\u20134","key":"16915_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000324704","volume":"80","author":"NE Kemeny","year":"2011","unstructured":"Kemeny NE, Schwartz L, G\u00f6nen M, et al. Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results? Oncology. 2011;80(3\u20134):153\u20139.","journal-title":"Oncology."},{"issue":"4","key":"16915_CR8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jso.24898","volume":"117","author":"LM Pak","year":"2018","unstructured":"Pak LM, Kemeny NE, Capanu M, et al. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: long term results and curative potential. J Surg Oncol. 2018;117(4):634\u201343.","journal-title":"J Surg Oncol."},{"issue":"2","key":"16915_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1245\/s10434-023-14515-y","volume":"31","author":"LM Janczewski","year":"2024","unstructured":"Janczewski LM, Ellis RJ, Lidsky ME, D\u2019Angelica MI, Merkow RP. Hepatic artery infusion chemotherapy: a quality framework. Ann Surg Oncol. 2024;31(2):701\u20134.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"16915_CR10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/SLA.0000000000005434","volume":"276","author":"JM Sharib","year":"2022","unstructured":"Sharib JM, Creasy JM, Wildman-Tobriner B, et al. Hepatic artery infusion pumps: a surgical toolkit for intraoperative decision-making and management of hepatic artery infusion-specific complications. Ann Surg. 2022;276(6):943\u201356.","journal-title":"Ann Surg."},{"key":"16915_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/ales-21-19","volume":"7","author":"LI Amodu","year":"2022","unstructured":"Amodu LI, Howell RS, Daskalaki D, Allendorf JD. Oncologic benefits of laparoscopic and minimally invasive surgery: a review of the literature. Ann Laparosc Endosc Surg. 2022;7:5.","journal-title":"Ann Laparosc Endosc Surg."},{"issue":"11","key":"16915_CR12","first-page":"CD001546","volume":"11","author":"T Jaschinski","year":"2018","unstructured":"Jaschinski T, Mosch CG, Eikermann M, Neugebauer EA, Sauerland S. Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev. 2018;11(11):CD001546.","journal-title":"Cochrane Database Syst Rev."},{"key":"16915_CR13","first-page":"CD006231","volume":"4","author":"F Keus","year":"2006","unstructured":"Keus F, de Jong JA, Gooszen HG, van Laarhoven CJ. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev. 2006;4:CD006231.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"16915_CR14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00464-003-8275-x","volume":"18","author":"YW Novitsky","year":"2004","unstructured":"Novitsky YW, Litwin DE, Callery MP. The net immunologic advantage of laparoscopic surgery. Surg Endosc. 2004;18(10):1411\u20139.","journal-title":"Surg Endosc."},{"issue":"6","key":"16915_CR15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1245\/ASO.2004.05.013","volume":"11","author":"J Cheng","year":"2004","unstructured":"Cheng J, Hong D, Zhu G, Swanstrom LL, Hansen PD. Laparoscopic placement of hepatic artery infusion pumps: technical considerations and early results. Ann Surg Oncol. 2004;11(6):589\u201397.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"16915_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00129689-200212000-00003","volume":"12","author":"ME Franklin Jr","year":"2002","unstructured":"Franklin ME Jr, Gonzalez JJ Jr. Laparoscopic placement of hepatic artery catheter for regional chemotherapy infusion: technique, benefits, and complications. Surg Laparosc Endosc Percutan Tech. 2002;12(6):398\u2013407.","journal-title":"Surg Laparosc Endosc Percutan Tech."},{"issue":"5","key":"16915_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hpb.2016.12.015","volume":"19","author":"M Qadan","year":"2017","unstructured":"Qadan M, D\u2019Angelica MI, Kemeny NE, Cercek A, Kingham TP. Robotic hepatic arterial infusion pump placement. HPB (Oxford). 2017;19(5):429\u201335.","journal-title":"HPB (Oxford)."},{"issue":"20","key":"16915_CR18","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895\u2013904.","journal-title":"N Engl J Med."},{"issue":"3","key":"16915_CR19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jso.24325","volume":"114","author":"M Dhir","year":"2016","unstructured":"Dhir M, Zenati MS, Padussis JC, et al. Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach. J Surg Oncol. 2016;114(3):342\u20137.","journal-title":"J Surg Oncol."},{"issue":"6","key":"16915_CR20","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1245\/s10434-024-15127-w","volume":"31","author":"B Ten Haaft","year":"2024","unstructured":"Ten Haaft B, Franssen S, van Dorst R, et al. Robotic versus open hepatic arterial infusion pump placement for unresectable intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2024;31(6):4022\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"16915_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","volume":"201","author":"PJ Allen","year":"2005","unstructured":"Allen PJ, Nissan A, Picon AI, et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005;201(1):57\u201365.","journal-title":"J Am Coll Surg."},{"issue":"2","key":"16915_CR22","first-page":"215","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9(2):215\u201334.","journal-title":"Int J Biostat."},{"key":"16915_CR23","unstructured":"R Core Team. R: a language and environment for statistical computing. 2021. Available at: https:\/\/www.r-project.org\/. Accessed 8 Dec 2023."},{"issue":"1","key":"16915_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg DD, Whiting K, Curry M, Lavery JA, Larmarange J. Reproducible summary tables with the gtsummary package. R J. 2021;13(1):570.","journal-title":"R J"},{"issue":"43","key":"16915_CR25","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. JOSS J Open Source Softw. 2019;4(43):1686.","journal-title":"JOSS J Open Source Softw"},{"key":"16915_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/9781118715598.ch17","volume-title":"Guidelines for reporting health research: a user\u2019s manual","author":"M Cevallos","year":"2014","unstructured":"Cevallos M, Egger M. STROBE (STrengthening the Reporting of Observational studies in Epidemiology). In: D Moher, DG Altman, KF Schulz, I Simera, E Wager, editors. Guidelines for reporting health research: a user\u2019s manual. Wiley; 2014. p. 169\u201379."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-16915-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:03:46Z","timestamp":1744095826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-16915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["16915"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-16915-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alice C. Wei reports receiving consulting fees from Histosonics and institutional clinical trial funding from Ipsen. Sabino Zani reports consulting for Asensus Surgical. Jeffrey Drebin reports equity shares in ALNY, IONS and ARWR, purchased from a broker. Lauren E. Schleimer, Annie Liu, Hannah L. Kalvin, Ahmad Bashir Barekzai, Ankur P. Choubey, Joslyn Jung, Rubiya Haque, William R. Jarnagin, Vinod P. Balachandran, Ruben Geevarghese, Brett Marinelli, Mithat Gonen, Peter J. Allen, Michael I. D\u2019Angelica, T. Peter Kingham, Michael E. Lidsky, and Kevin C. Soares have no conflicts of interest disclosures to report that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}